China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.
China SXT Pharmaceuticals Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
China SXT Pharmaceuticals Incの収益はセグメントまたは地域別にどのように分けられていますか?
China SXT Pharmaceuticals Inc の最大収益セグメントは Advanced Traditional Chinese Medicine Pieces で、最新の利益発表における収益は 946,015 です。地域別に見ると、China が China SXT Pharmaceuticals Inc の主要市場であり、収益は 1,928,497 です。